Pharmagreen Biotech Inc. (PHBI)
| Previous Close | 0.0007 |
| Open | 0.0006 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0006 - 0.0008 |
| 52 Week Range | 0.0003 - 0.0059 |
| Volume | |
| Avg. Volume | 1,485,675 |
| Market Cap | 464,552 |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREPHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its’ Nutraceutical Formulations
CARSON CITY, NV / ACCESSWIRE / January 24, 2024 / Pharmagreen Biotech, Inc., (OTC PINK:PHBI), "Pharmagreen" or the "Company" is pleased to announce the signing of a supply agreement with SierraSil® Health Inc., a manufacturer specializing in a proprietary ...
GlobeNewswirePHBI – Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.com and Develops Its Next Pre-Workout Formulation
CARSON CITY, NV, Sept. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), “Pharmagreen” or the “Company” is pleased to announce that it has been approved by Amazon Seller Central for online sales via Amazon’s e-commerce platform for its MaxGenomicTM Supplement. https://www.amazon.com/dp/B0C9C656KR?ref=myi_title_dp The company is also developing additional sales channels, both online and brick-and-mortar, for the MaxGenomicTM supplements. Pharmagreen’s l
